These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the principle of concentrating on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-linked Diseases. Determined by available science the https://shulamithw466drf4.activablog.com/profile